Group One Trading
SRPT icon

Group One Trading’s Sarepta Therapeutics SRPT Stock Holding History

Group One Trading’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.6M Sell
626,700
-297,900
-32% -$5.77M 0.03% 668
2025
Q4 		$19.9M Buy
924,600
+146,200
+19% +$3.08M 0.03% 555
2025
Q3 		$15M Sell
778,400
-775,700
-50% -$13.8M 0.03% 658
2025
Q2 		$26.6M Buy
1,554,100
+1,368,900
+739% +$58.4M 0.06% 328
2025
Q1 		$11.8M Buy
185,200
+48,900
+36% +$5.15M 0.03% 550
2024
Q4 		$16.6M Buy
136,300
+12,000
+10% +$1.47M 0.04% 456
2024
Q3 		$15.5M Sell
124,300
-45,000
-27% -$6.22M 0.04% 384
2024
Q2 		$26.7M Sell
169,300
-6,500
-4% -$835K 0.1% 140
2024
Q1 		$22.8M Sell
175,800
-156,300
-47% -$19.1M 0.09% 157
2023
Q4 		$32M Buy
332,100
+135,400
+69% +$13M 0.08% 178
2023
Q3 		$23.8M Buy
196,700
+60,000
+44% +$6.78M 0.08% 178
2023
Q2 		$15.7M Sell
136,700
-1,400
-1% -$181K 0.05% 328
2023
Q1 		$19M Sell
138,100
-265,400
-66% -$34.4M 0.07% 227
2022
Q4 		$52.3M Buy
403,500
+107,300
+36% +$12.4M 0.12% 138
2022
Q3 		$32.7M Buy
296,200
+19,700
+7% +$1.99M 0.06% 221
2022
Q2 		$20.7M Sell
276,500
-192,600
-41% -$14.2M 0.03% 465
2022
Q1 		$36.6M Buy
469,100
+199,400
+74% +$15.3M 0.04% 354
2021
Q4 		$24.3M Buy
269,700
+145,700
+118% +$12.5M 0.02% 588
2021
Q3 		$11.5M Sell
124,000
-20,800
-14% -$1.6M 0.01% 973
2021
Q2 		$11.3M Sell
144,800
-36,700
-20% -$2.78M 0.01% 992
2021
Q1 		$13.5M Sell
181,500
-79,000
-30% -$7.29M 0.02% 747
2020
Q4 		$44.4M Buy
260,500
+34,000
+15% +$5.04M 0.08% 214
2020
Q3 		$31.8M Sell
226,500
-5,900
-3% -$897K 0.1% 161
2020
Q2 		$37.3M Buy
232,400
+27,400
+13% +$3.73M 0.17% 91
2020
Q1 		$20.1M Sell
205,000
-166,100
-45% -$19M 0.16% 98
2019
Q4 		$47.9M Buy
371,100
+73,500
+25% +$7.42M 0.33% 33
2019
Q3 		$22.4M Buy
297,600
+40,500
+16% +$4.78M 0.18% 93
2019
Q2 		$39.1M Sell
257,100
-20,800
-7% -$2.53M 0.35% 29
2019
Q1 		$33.1M Buy
277,900
+86,300
+45% +$11.1M 0.37% 29
2018
Q4 		$20.9M Sell
191,600
-102,400
-35% -$12.8M 0.18% 102
2018
Q3 		$47.5M Sell
294,000
-8,800
-3% -$1.2M 0.38% 29
2018
Q2 		$40M Buy
302,800
+7,600
+3% +$717K 0.34% 32
2018
Q1 		$21.9M Buy
295,200
+48,700
+20% +$3.25M 0.22% 80
2017
Q4 		$13.7M Sell
246,500
-88,000
-26% -$4.66M 0.1% 242
2017
Q3 		$15.2M Buy
334,500
+113,400
+51% +$4.53M 0.14% 154
2017
Q2 		$7.45M Sell
221,100
-22,400
-9% -$729K 0.08% 312
2017
Q1 		$7.21M Sell
243,500
-497,600
-67% -$15.4M 0.08% 279
2016
Q4 		$20.3M Sell
741,100
-351,100
-32% -$14.1M 0.2% 96
2016
Q3 		$67.1M Sell
1,092,200
-384,300
-26% -$11.6M 0.73% 9
2016
Q2 		$28.2M Buy
1,476,500
+1,019,600
+223% +$18.9M 0.33% 42
2016
Q1 		$8.92M Buy
456,900
+27,100
+6% +$473K 0.13% 162
2015
Q4 		$16.6M Buy
429,800
+104,900
+32% +$3.4M 0.2% 77
2015
Q3 		$10.4M Sell
324,900
-2,200
-0.7% -$74.6K 0.14% 140
2015
Q2 		$9.95M Buy
327,100
+78,700
+32% +$1.61M 0.14% 146
2015
Q1 		$3.3M Sell
248,400
-240,100
-49% -$3.2M 0.05% 407
2014
Q4 		$7.07M Buy
488,500
+46,600
+11% +$789K 0.11% 188
2014
Q3 		$9.32M Buy
441,900
+133,800
+43% +$3.02M 0.14% 128
2014
Q2 		$9.18M Sell
308,100
-103,700
-25% -$3.28M 0.14% 135
2014
Q1 		$9.9M Sell
411,800
-9,900
-2% -$252K 0.17% 105
2013
Q4 		$8.59M Buy
421,700
+101,000
+31% +$3M 0.13% 135
2013
Q3 		$15.1M Buy
320,700
+182,200
+132% +$7.02M 0.29% 50
2013
Q2 		$5.27M Buy
+138,500
New +$4.95M 0.13% 143

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's SRPT Position: Q1 2026 in Review

Group One Trading reduced its Sarepta Therapeutics (SRPT) stake by 29% in Q1 2026, selling an estimated $791K and leaving 99,915 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

Group One Trading first reported a position in SRPT in Q2 2013 and has held it in 41 quarters since. The position peaked at $27.8M in Q1 2023. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Group One Trading held 99,915 shares of Sarepta Therapeutics worth $2.17M as of Q1 2026.
  • Group One Trading sold 40,859 Sarepta Therapeutics shares in Q1 2026, an estimated $791K.
  • Sarepta Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #1996 holding.
  • Group One Trading first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 41 quarters since.
  • Group One Trading's Sarepta Therapeutics position peaked at $27.8M in Q1 2023.
  • 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.